Incorporating frailty in a multi-state model: Application to disease natural history modelling of adenoma-carcinoma in the large bowel

Statistical Methods in Medical Research

Volumn 19, Issue 5, 2010, Pages 529-546

  Yen, Amy M F ^a   Chen, Tony H H ^a   Duffy, Stephen W ^b   Chen, Chih Dao ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; CANCER GROWTH; CARCINOMA; COLORECTAL CANCER; DISEASE MODEL; HUMAN; LARGE INTESTINE CANCER; REVIEW; STATISTICAL MODEL; TUMOR VOLUME;

ADENOCARCINOMA; AGED; COLONIC NEOPLASMS; FRAIL ELDERLY; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; PRECANCEROUS CONDITIONS;

EID: 77957812138     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280209359862     Document Type: Review

References (38)

1. Chen THH, Duffy SW, Tabar L. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. The Statistician 1996 ; 45: 307-317.
2. Launoy G., Smith TC, Duffy SW, Bouvier V. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. International Journal of Cancer 1997 ; 73: 220-224.
3. Prevost TC, Launoy G., Duffy SW, Chen HH Estimating sensitivity and sojourn time in screening for colorectal cancer: A comparison of statistical approaches. American Journal of Epidemiology 1998 ; 148: 609-619.
4. Day NE, Walter SD Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984 ; 40: 1-14.
5. van Oortmarssen GJ, Habbema JD Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears. International Journal of Epidemiology 1995 ; 24: 300-307.
6. Cole P., Morrison AS Basic issues in population screening for cancer. Journal of the National Cancer Institute 1980 ; 64: 1263-1272.
7. Kronborg O. Colon polyps and cancer. Endoscopy 2004 ; 36: 3-7.
8. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New England Journal of Medicine 1993 ; 329: 1977-1981.
9. Kuffer R., Lombardi T. Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN). Oral Oncology 2002 ; 38: 125-130.
10. Laara E., Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987 ; 1: 1247-1249.
11. Cafferty FH, Sasieni PD, Duffy SW A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance. Statistical Method in Medicine Research 2009 ; 18: 163-182.
12. Rutter CM, Yu O., Miglioretti DL A hierarchical non-homogeneous Poisson model for meta-analysis of adenoma counts. Statistics in Medicine 2007 ; 26: 98-109.
13. Kudo S., Kashida H., Tamura T. Early colorectal cancer: flat or depressed type. Journal of the Gastroenterology and Hepatology 2000 ; 15 (Suppl): D66 - D70.
14. Chen CD, Yen MF, Wang WM, Wong JM, Chen TH A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: Implication for efficacy of colonoscopy. British Journal of Cancer 2003 ; 88: 1866-1873.
15. Labropoulou EP, Datsis A., Kekelos S., et al. Colorectal carcinoma: Contribution of growth pattern on prognosis. Technical Coloproctology 2004 ; 8: s208-10.
16. Koga Y., Yao T., Hirahashi M., et al. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and β-catenin expression: A different pathway from the polypoid adenoma-carcinoma sequence. Histopathology 2008 ; 52: 569-577.
17. Soetikno RM, Kaltenbach T., Rouse RV, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2009 ; 299: 1027-1035.
18. Chiu HM, Lin JT, Chen CC, et al. Prevalence and characteristics of nonpolypoid colorectal neoplasm in an asymptomatic and average-risk Chinese population. Clinical Gastroenterology and Hepatology 2009 ; 7: 463-470.
19. Terhaar Sive Droste JS, Craanen ME, et al. Colonoscopic yield of colorectal neoplasia in daily clinical practice. World Journal of Gastroenterology 2009 ; 15: 1085-1092.
20. Lieberman D., Moravec M., Holub J., Michaels L., Eisen G. Polyp size and advanced histology in patients undergoing colonoscopy screening: Implications for CT colonography. Gastroenterology 2008 ; 135: 1100-1105.
21. Aalen OO Effects of frailty in survival analysis. Statistical Methods in Medical Research 1994 ; 3: 227-243.
22. Aalen OO, Tretli S. Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 1999 ; 10: 285-292.
23. Halloran ME, Longini IM, Struchiner CJ Estimability and interpretation of vaccine efficacy using frailty mixing models. American Journal of Epidemiology 1996 ; 144: 83-97.
24. Hougaard P. Survival models for heterogeneous populations derived from stable-distributions. Biometrika 1986 ; 73: 386-396.
25. Chen TH, Kuo HS, Yen MF, Lai MS, Tabar L., Duffy SW Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 2000 ; 56: 167-172.
26. Chen TH, Yen MF, Shiu MN, Tung TH, Wu HM Stochastic model for non-standard case-cohort design. Statistics in Medicine 2004 ; 23: 633-647.
27. Duffy SW, Chen HH, Tabar L., Day NE Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statistics in Medicine 1995 ; 14: 1531-1543.
28. Myers ER, McCrory DC, Subramanian S., et al. Setting the target for a better cervical screening test: Characteristics of a cost-effective test for cervical neoplasia screening. Obstetrics & Gynecology 2000 ; 96: 645-652.
29. Pokorski RJ Long-term morbidity and mortality risk in Japanese insurance applicants with chronic hepatitis C virus infection. Journal of Insurance and Medicine 2001 ; 33: 12-36.
30. Yang KC, Liao CS, Chiu YH, Yen AMF, Chen THH. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: An experience from Keelung, Taiwan. Journal of Medical Screening 2006 ; 13: S8 - S13.
31. Hougaard P. Life table methods for heterogeneous populations - Distributions describing the heterogeneity. Biometrika 1984 ; 71: 75-83.
32. Aalen OO Modelling heterogeneity in survival analysis by the compound Poisson distribution. The Annals of Applied Probability 1992 ; 2: 951-972.
33. Chen HH, Duffy SW, Tabar L. A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumour progression in breast cancer. Journal of Applied Statistics 1997 ; 24: 265-278.
34. Chen HH, Duffy SW, Tabar L., Day NE Markov chain models for progression of breast cancer part I: Tumour attributes and the preclinical screen-detectable phase. Journal of Epidemiology and Biostatistics 1997 ; 2: 9-23.
35. Cox DR, Miller HD The theory of stochastic process. Methuen, London ; 1965.
36. SAS Institute Inc. SAS/IML (R) Software: Changes and enhancements through Release 6.11. SAS Institute Inc., Cary, NC ; 1998.
37. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL Natural history of untreated colonic polyps. Gastroenterology 1987 ; 93: 1009-1013.
38. Bertario L., Russo A., Sala P., et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. International Journal of Cancer 2003 ; 105: 82-87.